Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpatialX is a biotechnology company specializing in high-throughput spatial biology to transform precision medicine and drug discovery. The company's platform integrates advanced imaging, molecular biology, and machine learning to provide high-resolution maps of gene and protein expression within the tissue microenvironment. By enabling the visualization of cellular interactions at scale, SpatialX supports researchers in identifying novel biomarkers and understanding complex disease mechanisms, particularly in oncology and immunology. The company focuses on bridging the gap between high-dimensional spatial data and clinical applications, aiming to improve patient stratification and therapy selection. Their technology is designed to be compatible with standard clinical samples, facilitating the translation of spatial insights into diagnostic tools. SpatialX leverages its proprietary Spatial-to-Clinic pipeline to accelerate the development of personalized therapeutic strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SpatialX Diagnostics.